Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 13Gastrointestinal 12Thoracic 11Other hematologic neoplasm 9Lymphoid 7Genitourinary 5Other solid neoplasm 4Gynecologic 4Other 3Plasma cell 2Head & Neck 2Other neoplasm 1Myeloid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Oropharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 630Radiotherapy 339pembrolizumab 329Cetuximab 283Docetaxel 225Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 76toripalimab 74Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 48Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 43130-nm albumin-bound paclitaxel 43tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Exercise Test × Head & Neck × Clear all
NCT05890859 2023-06-06

Lean Body Mass in Head and Neck Cancer Patients During Cisplatin-based Chemoradiation

Department of Public Health, Denmark

Phase NA Completed
48 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02628912 2018-01-04

Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers

Memorial Sloan Kettering Cancer Center

Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡